Steven Camp
Plastic Surgery · Fort Worth, TXNPI 1235267519
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (49.9%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 93.3% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2022 at $57,150 and has fallen 73.0% since, to $15,454 in 2025. Among plastic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 399 payments — averaging $398.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$148K
- Motiva USA, LLC$4K
- Davol Inc.$4K
- Tepha Inc$1K
- Sientra, Inc.$597
- Galderma Laboratories, L.p.$316
- plus $768 from 9 others
Across 12 payments — averaging $1132.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Motiva USA, LLC$14K
What the payments were for
- Consulting fees$60,40138%
- Speaking & faculty fees$79,41350%
- Travel & lodging$3,5072%
- Food & beverage$15,68410%
- Gifts$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 298 | $148,437 |
| Motiva USA, LLC | 19 | $4,142 |
| Davol Inc. | 35 | $3,715 |
| Tepha Inc | 14 | $1,118 |
| Sientra, Inc. | 8 | $597 |
| Galderma Laboratories, L.p. | 9 | $316 |
| Revance Therapeutics, Inc. | 4 | $219 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $169 |
| TELA Bio, Inc. | 1 | $149 |
| Smith+Nephew | 2 | $93 |
| Merz North America, Inc. | 1 | $47 |
| Apyx Medical Corporation | 1 | $26 |
| Vertex | 1 | $25 |
| Integra Lifesciences Corporation | 1 | $20 |
| KCI USA, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$159,091 in reported general payments places this provider in the 95th percentile of 337 plastic surgery providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 11 | $40 |
| Cephalexin | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Fort Worth
- Danielle LeblancFort Worth$12K
- Younghoon ChoHouston$1.2M
- David AdelmanHouston$405K
- Rodney RohrichDallas$388K
- Regina FearmontiSan Antonio$340K
- Warren EllsworthHouston$284K
- Camille CashHouston$212K
- Robert YarishHouston$180K
- Gerhard MundingerWest Lake Hills$166K
- Alexander MericliHouston$125K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.